Evonetix installs first DNA synthesis development platform at ICL
It will be the company’s first platform to be installed in an external scientific setting
Read More
Tag: Evonetix
Cambridge University receives first synthesized DNA from Evonetix
Transfer marks start of vital development stage as company expands its range of synthesized DNA
Read More
Vital funding established for Evonetix projects
Financing will allow company’s development of DNA synthesis chip technology to commercial scale
Read More
Evonetix commences access programme for synthesised DNA
Researchers are invited to apply to receive DNA that has been synthesised using Evonetix’s platform
Read More
Patent granted for Evonetix’s thermally-controlled DNA synthesis
In contrast to conventional methods, Evonetix uses thermal control which offers greater accuracy and selectivity
Read More
Evonetix raises £9m for novel gene synthesis tech
Cambridge, UK-based Evonetix has raised £9 million to help fuel the advance of its technology designed to enable scalable and high-fidelity gene synthesis.
Read More
- TARA-002 shows strong early results in trial for paediatric lymphatic malformations
- Libtayo approved in EU as first adjuvant immunotherapy for high-risk CSCC
- Cellbyte raises $2.75m to slash drug launch timelines with AI
- GSK and Imperial launch £45m AI-powered AMR research drive
- Scottish Brain Sciences opens new Alzheimer’s research centre in Aberdeen
